In laboratory animals, synthetic and natural estrogens are known to induce tumors. Previously, it was found that estrogens induce target-organ specific DNA damage preceding malignancy in hamster kidney. In this study, it will be attempted to prove that this DNA damage was caused by estrogens metabolically activated to reactive metabolites which then induced unknown endogenous substances to bind covalently to DNA. In particular, it will be attempted to a) clarify the structures of the estrogen-induced DNA adducts, b) determine the pathway of adduct formation, c) establish estrogen induced DNA adducts in human tissue and in animal models other than the Syrian hamster kidney as a cause of estrogen-induced cancer. Specifically the following experiments will be carried out: 1. Characterization of the structure and formation of DNA adducts. DNA adducts will be tested for structural features by chemical and enzymatic reactions. Differing DNA adduct patterns after (bio)chemical alterations will indicate the presence of unsaturated sites, carbonyles, lipid, carbohydrate, carboxyl groups, or other features of the estrogen-induced DNA adducts. Adducts will be synthesized in vitro. Reaction conditions will be varied to a) find in vitro conditions for DNA adduct formation, b) optimize adduct yield, c) obtain sufficient amounts of adducts for structure determination, d) define the conditions and pathway of adduct formation. 2. Increased adduct yields will be searched for in hamster kidney cell subpopulations and also in mammalian and yeast cell lines known to be transformed by estrogens. 3. The occurrence of estrogen-induced DNA adducts will be searched for in human tissues (target organ of estrogen-associated cancer) and in various rodent target organs. 4. Estrogen-induced DNA adduct patterns will be compared with adducts induced by redox-cycling agents (daunomycin) or radiation to investigate the role of redox cycling or radicals. 5. To understand the mechanism of adduct formation in vivo, hamster renal carcinogenesis and adduct formation will be modulated using enzyme inhibitors or antiestrogens. 6. The mechanism of activation of estrogens in hamster kidney by cytochrome P450, peroxidase, and/or prostaglandin endoperoxide synthase will be studied. Especially, the role of redox cycling and radical formation will be investigated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA043233-05
Application #
3482541
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1986-08-01
Project End
1991-07-31
Budget Start
1989-08-01
Budget End
1990-07-31
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Winter, M L; Liehr, J G (1996) Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs. Toxicol Appl Pharmacol 136:211-9
Zhu, B T; Liehr, J G (1996) Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis. J Biol Chem 271:1357-63
Wang, M Y; Liehr, J G (1995) Lipid hydroperoxide-induced endogenous DNA adducts in hamsters: possible mechanism of lipid hydroperoxide-mediated carcinogenesis. Arch Biochem Biophys 316:38-46
Han, X; Liehr, J G (1995) Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis 16:2571-4
Winter, M L; Bosland, M C; Wade, D R et al. (1995) Induction of benign prostatic hyperplasia in intact dogs by near-physiological levels of 5 alpha-dihydrotestosterone and 17 beta-estradiol. Prostate 26:325-33
Han, X; Liehr, J G; Bosland, M C (1995) Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone. Carcinogenesis 16:951-4
Liehr, J G; Ricci, M J; Jefcoate, C R et al. (1995) 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci U S A 92:9220-4
Wang, M Y; Liehr, J G (1995) Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis 16:1941-5
Li, D; Wang, M; Liehr, J G et al. (1995) DNA adducts induced by lipids and lipid peroxidation products: possible relationships to I-compounds. Mutat Res 344:117-26
Moorthy, B; Liehr, J; Randerath, E et al. (1995) Evidence from 32P-postlabeling and the use of pentachlorophenol for a novel metabolic activation pathway of diethylstilbestrol and its dimethyl ether in mouse live: likely alpha-hydroxylation of ethyl group(s) followed by sulfate conjugation. Carcinogenesis 16:2643-8

Showing the most recent 10 out of 45 publications